TAMMI LABARRE: Open Payments
NPI 1992990626 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 17 payments from 7 companies in 2025. Trend: 2023 $530 · 2024 $717 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $116 |
| Axsome Therapeutics, Inc. | 4 | $69 |
| Noven Therapeutics, LLC | 2 | $41 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| TOLMAR, INC. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
Products named: CAPLYTA, Auvelity, Xelstrym, JATENZO, XYOSTED, BOTOX, HORIZANT, AZMIRO.
Industry payments across LA — which companies pay providers there.
